SCHEMBL6955439

SCHEMBL6955439

Fc1cccc(Cl)c1CCNC(=S)Nc1ncc[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.46
ADRA2A P08913 1/20 0.43
ADRA2C P18825 1/20 0.43
ADRA1D P25100 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43
KDM4E B2RXH2 1/20 0.42
PTGES O14684 1/20 0.41
TAAR1 Q96RJ0 3/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
MAPK1 P28482 1/20 0.41
PTPN7 P35236 1/20 0.41
DUSP3 P51452 1/20 0.41
PTPN5 P54829 1/20 0.41
PTPN11 Q06124 1/20 0.41
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954353 0.92 RAB9A (0.42) PTGESNPC1RAB9ACYP1A2CYP3A4
SCHEMBL6958454 0.92 ADRA2A (0.48) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL6962193 0.84 GAA (0.44) MAPK1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL6960518 0.83 LMNA (0.40) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL6957231 0.83 KMT2A (0.47) PTGESNPC1RAB9AMAPK1CYP1A2
SCHEMBL6956364 0.81 KDM4E (0.48) CNR1ADRA2AADRA2CADRA1DADRA1A
SCHEMBL6965203 0.81 MEN1 (0.47) CNR1KDM4ETAAR1NPC1RAB9A
SCHEMBL6954180 0.80 PTGES (0.38) KDM4EPTGESNPC1RAB9ACYP1A2
SCHEMBL6953499 0.79 NPC1 (0.51) CNR1KDM4ENPC1RAB9AMAPK1
SCHEMBL6953259 0.79 ALDH1A1 (0.60) CNR1KDM4ETAAR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0540143-B1 Compounds and methods for inhibition of HIV and related viruses MEDIVIR AB (SE) 2003-02-05 EP disclosed
US-5714503-A Compounds and methods for inhibition of HIV and related viruses MEDIVIR AB (SE) 1998-02-03 US disclosed
US-5593993-A VIRICIDES FOR HTLV TREATMENT OF AIDS MEDIVIR AB (SE) 1997-01-14 US disclosed
EP-0540143-A2 Compounds and methods for inhibition of HIV and related viruses Medivir Aktiebolag (SE) 1993-05-05 EP disclosed
WO-1993003022-A1 COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES MEDIVIR AB (SE) 1993-02-18 WO disclosed